ArborMetrix

About ArborMetrix

ArborMetrix, Inc. operates as a healthcare analytics company, providing data-driven solutions to improve clinical and financial outcomes. Founded in 2011 by John D. Birkmeyer and Justin Dimick, the company originated from technology developed at the University of Michigan and Dartmouth University. Birkmeyer, who also serves as the Chief Scientific Officer, leveraged his research on improving surgical quality and econometric performance measurement to establish the company's core technology. The firm is headquartered in Ann Arbor, Michigan, and has secured approximately $34.5 million in funding over 14 rounds from investors including RPM Ventures, Arboretum Ventures, and the Renaissance Venture Capital Fund.

The company's business model is centered on a subscription-based Software-as-a-Service (SaaS) platform. ArborMetrix serves a diverse client base that includes healthcare providers, payers, medical specialty societies, research institutions, and government entities across the United States. Revenue is generated through annual licensing agreements for its software solutions, which empower these organizations to track performance metrics, reduce costs, and enhance patient care. The platform is designed to integrate and analyze large, complex datasets from clinical, financial, and operational sources to provide actionable insights.

ArborMetrix offers a suite of products, including AMxEngage, AMxEquity, RegistryMetrix, and SurgicalMetrix. These cloud-based tools provide performance measurement, clinical intelligence, and real-time data dashboards without requiring significant IT resources from the client. A key feature is the ability to integrate surgical video analysis, allowing for peer review and evaluation of surgeons' technical skills to improve outcomes. The platform delivers clinically deep, risk-adjusted analytics that help identify variations in care and measure the effectiveness of treatments, medical devices, and pharmaceuticals. Recent product launches include AMxEquity, which focuses on health equity analytics, and AMxEngage: AdvancedPRO, aimed at enhancing patient engagement. The solutions are utilized for post-market surveillance of medical devices, to support regulatory and payment strategies, and to advance clinical research by transforming real-world data into evidence.